ArticleClinical Medicine Insights. Oncology2024

Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 2022.

David J Benjamin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.